Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
1289×1383
Safety And Efficacy Of Administering Reduced Doses Of Pegylated
Safety And Efficacy Of Administering Reduced Doses Of Pegylated
2128×1701
Recombinant Human Coagulation Factor Ix Protein Cf 9260 Se By Randd
Recombinant Human Coagulation Factor Ix Protein Cf 9260 Se By Randd
905×684
Pdf Pharmacokinetics And Safety Of Pegylated Recombinant Human
Pdf Pharmacokinetics And Safety Of Pegylated Recombinant Human
850×1202
Application Of Pegylated Recombinant Human Granulocyte Colon
Application Of Pegylated Recombinant Human Granulocyte Colon
1200×288
Frontiers Reduced Effectiveness And Comparable Safety In Biweekly Vs
Frontiers Reduced Effectiveness And Comparable Safety In Biweekly Vs
1521×1160
Pdf Safety Of Pegylated Recombinant Human Full‐length Coagulation
Pdf Safety Of Pegylated Recombinant Human Full‐length Coagulation
850×1126
Safety Antitumor Activity And Immune Activation Of Pegylated
Safety Antitumor Activity And Immune Activation Of Pegylated
1036×1483
Pdf Pegylated Full Length Recombinant Factor Viii For Prophylactic
Pdf Pegylated Full Length Recombinant Factor Viii For Prophylactic
850×1121
Ijms Free Full Text Engineering Crisprcas9 For Multiplexed
Ijms Free Full Text Engineering Crisprcas9 For Multiplexed
3300×1411
Coagulation Factor Viia Recombinant Human Uses Interactions
Coagulation Factor Viia Recombinant Human Uses Interactions
500×500
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
622×225
Pdf Efficacy And Safety Of 3 Mg Pegylated Recombinant Human
Pdf Efficacy And Safety Of 3 Mg Pegylated Recombinant Human
850×1118
Nonclinical Safety Assessment Of A Long Acting Recombinant Pegylated
Nonclinical Safety Assessment Of A Long Acting Recombinant Pegylated
1035×1519
Pdf Effect And Safety Of Pegylated Recombinant Human G Csf On
Pdf Effect And Safety Of Pegylated Recombinant Human G Csf On
850×1153
Pdf Correction To Efficacy And Safety Of Full Length Pegylated
Pdf Correction To Efficacy And Safety Of Full Length Pegylated
850×1129
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
758×1000
Development Validation And Application Of A Novel Ligand Binding
Development Validation And Application Of A Novel Ligand Binding
1200×628
Schematic Diagram Of The Treatment Process Peg Rhg Csf Pegylated
Schematic Diagram Of The Treatment Process Peg Rhg Csf Pegylated
640×640
Safety Antitumor Activity And Immune Activation Of Pegylated
Safety Antitumor Activity And Immune Activation Of Pegylated
2752×1411
Pdf Extended Half Life Pegylated Full Length Recombinant Factor Viii
Pdf Extended Half Life Pegylated Full Length Recombinant Factor Viii
850×1126
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
Safety Of Pegylated Recombinant Human Full‐length Coagulation Factor
500×211
Pdf Efficacy And Safety Of Pegylated Full Length Recombinant Factor
Pdf Efficacy And Safety Of Pegylated Full Length Recombinant Factor
850×1126
Pdf Perioperative Haemostasis With Full‐length Pegylated
Pdf Perioperative Haemostasis With Full‐length Pegylated
850×1118
Pdf Pegylated Recombinant Human Growth Hormone Jintrolong® Exhibits
Pdf Pegylated Recombinant Human Growth Hormone Jintrolong® Exhibits
850×1113
Pharmacokinetics And Safety Of Pegylated Recombinant Human Granulocyte
Pharmacokinetics And Safety Of Pegylated Recombinant Human Granulocyte
1962×2722
Pdf Safety And Efficacy Of Pegylated Recombinant Human Granulocyte
Pdf Safety And Efficacy Of Pegylated Recombinant Human Granulocyte
850×1100
Frontiers Reduced Effectiveness And Comparable Safety In Biweekly Vs
Frontiers Reduced Effectiveness And Comparable Safety In Biweekly Vs
1520×1081
Original Article Efficacy Safety And Tolerance Of Peg Endo An N
Original Article Efficacy Safety And Tolerance Of Peg Endo An N
400×550
Pdf Chinese Expert Consensus On The Application Of Pegylated
Pdf Chinese Expert Consensus On The Application Of Pegylated
850×1118
Pdf Clinical Implications Safety Efficacy Of Recombinant Human
Pdf Clinical Implications Safety Efficacy Of Recombinant Human
850×1202
Safety Antitumor Activity And Immune Activation Of Pegylated
Safety Antitumor Activity And Immune Activation Of Pegylated
2102×1866
Pdf Nonclinical Safety Assessment Of A Long Acting Recombinant
Pdf Nonclinical Safety Assessment Of A Long Acting Recombinant
850×1100
Pegylated Full Length Recombinant Factor Viii For Prophylactic And On
Pegylated Full Length Recombinant Factor Viii For Prophylactic And On
753×558
Efficacy And Safety Of Pegylated Full‐length Recombinant Factor Viii
Efficacy And Safety Of Pegylated Full‐length Recombinant Factor Viii
2128×2504
